Scleroderma, Diffuse: Clinical Trials

2 trials for Scleroderma, Diffuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2

Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
CNTY-101, IL-2, Lymphodepleting Chemotherapy - Systemic Lupus Erythematosus, Lupus Nephritis
Phase 1Active not recruitingCentury Therapeutics, Inc.62025-02-062026-01-08
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
KYV-101, Cyclophosphamide, Fludarabine - Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis
Phase 1Active not recruitingDavid Porter242024-08-052026-09-21

Narrower conditions

Lupus Nephritis (2)  ·  Myositis (2)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Autoimmune Diseases (1)  ·  Dermatomyositis (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Polymyositis (1)  ·  Scleroderma, Systemic (1)  ·  Sclerosis (1)

Broader conditions

Connective Tissue Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Glomerulonephritis (2)  ·  Immune System Diseases (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nephritis (2)  ·  Nervous System Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Urogenital Diseases (2)

Interventions

Cyclophosphamide (1)  ·  Interleukin-2 (1)  ·  fludarabine (1)

Sponsors

Century Therapeutics, Inc. (1)  ·  David Porter (1)

Countries

United States (2)